Home › Funds › Renaissance Technologies › CMPX
Renaissance Technologies position in CMPX
COMPASS THERAPEUTICS INC · Health Care
Latest position (Q3 2025)79.00K sh
Reported value held$276.50K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 13.30K | $18.00K | New |
| Q2 2022 | 66.17K | $175.00K | Add |
| Q3 2022 | 64.22K | $146.00K | Reduce |
| Q4 2022 | 51.90K | $261 | Reduce |
| Q1 2023 | 52.30K | $171 | Add |
| Q3 2023 | 26.80K | $53 | New |
| Q4 2023 | 176.80K | $276 | Add |
| Q1 2024 | 70.40K | $139 | Reduce |
| Q2 2024 | 140.60K | $140.60K | Add |
| Q3 2024 | 222.60K | $409.58K | Add |
| Q4 2024 | 278.60K | $403.97K | Add |
| Q1 2025 | 321.50K | $610.85K | Add |
| Q2 2025 | 224.60K | $583.96K | Reduce |
| Q3 2025 | 79.00K | $276.50K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CMPX
- Vanguard Group 8.05M sh · $43.22M · Q4 2025
- BlackRock Inc 11.28M sh · $24.71M · Q2 2026
- Millennium Management 4.71M sh · $10.32M · Q2 2026
- Geode Capital Management 3.82M sh · $8.36M · Q2 2026
- Citadel Advisors 3.71M sh · $8.12M · Q2 2026
- Goldman Sachs Group 3.53M sh · $7.73M · Q2 2026
- AQR Capital Management 3.51M sh · $7.69M · Q2 2026
- Royce & Associates 1.34M sh · $2.93M · Q2 2026
- Fidelity Management & Research (FMR) 1.21M sh · $2.65M · Q2 2026
- Northern Trust Corp 1.14M sh · $2.50M · Q2 2026
- JPMorgan Chase & Co 789.40K sh · $1.71M · Q2 2026
- Morgan Stanley 735.19K sh · $1.61M · Q2 2026